GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Long-Term Liabilities

Alto Neuroscience (Alto Neuroscience) Other Long-Term Liabilities : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Other Long-Term Liabilities?

Alto Neuroscience's other long-term liabilities for the quarter that ended in Mar. 2024 was $0.00 Mil.

Alto Neuroscience's quarterly other long-term liabilities increased from Sep. 2023 ($98.60 Mil) to Dec. 2023 ($142.83 Mil) but then declined from Dec. 2023 ($142.83 Mil) to Mar. 2024 ($0.00 Mil).

Alto Neuroscience's annual other long-term liabilities increased from Dec. 2021 ($39.46 Mil) to Dec. 2022 ($74.24 Mil) and increased from Dec. 2022 ($74.24 Mil) to Dec. 2023 ($142.83 Mil).

Alto Neuroscience Other Long-Term Liabilities Historical Data

The historical data trend for Alto Neuroscience's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Other Long-Term Liabilities Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Other Long-Term Liabilities
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial - - - - -

Alto Neuroscience Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Alto Neuroscience Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Other Long-Term Liabilities
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024